Evaluation of Splicing on X-box Binding Protein Transcript in Tissue Samples of Colorectal Cancer.

crc splicing xbp

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
19 Apr 2019
Historique:
entrez: 29 6 2019
pubmed: 30 6 2019
medline: 30 6 2019
Statut: epublish

Résumé

Background The genetic etiology of colorectal cancer (CRC) is the occurrence of mutation in the genes involved in signal transduction pathways including that of cellular responses to endoplasmic reticulum (ER) stress. This study examines alterations of pre-messenger ribonucleic acid (pre-mRNA) splicing in X-box binding protein (XBP) transcripts related to the ER stress pathway in CRC. Materials and methods In this study, samples were deparaffinized and underwent RNA extraction. A total of 30 synthesized complementary deoxyribonucleic acid (cDNA) templates from the extracted RNAs related to tumor and non-tumor CRC samples, collected over three years and containing pathological data, were subjected to semi-quantitative reverse transcriptase polymerase chain reaction (sqRT-PCR). These cDNA templates were amplified in reaction tubes with specific primers for both spliced and non-spliced isoforms of XBP. Results with P< .05 were considered statistically significant. Results Microscopic assessment represented lymphocyte-rich effusion in tumor samples. sqRT-PCR electrophoresis results showed spliced and non-spliced forms of XBP messenger RNA in the studied samples. In addition, our data showed there were more than 7.8 times the total number of spliced variants in the marginal tumor samples than in the tumor tissue samples (P<.05). Conclusion Alterations of expression in genes involved in stress signaling pathways in cancer have been identified previously. Our results showed an inverse relationship between XBP splicing and CRC tumor tissue, possibly lead to the inactivation of apoptosis in the downstream response to ER stress. However, we propose that the remaining genes in this pathway should undergo gene expression analysis using a greater number of samples.

Identifiants

pubmed: 31249762
doi: 10.7759/cureus.4500
pmc: PMC6584302
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e4500

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cancer Res. 2004 Sep 1;64(17):5943-7
pubmed: 15342372
J Hematol Oncol. 2011 Feb 23;4:8
pubmed: 21345215
Autophagy. 2017 May 4;13(5):781-819
pubmed: 28358273
Anticancer Res. 2013 Nov;33(11):4683-94
pubmed: 24222102
Blood. 2012 Jun 14;119(24):5772-81
pubmed: 22538852
Am J Respir Crit Care Med. 2014 Feb 1;189(3):239-40
pubmed: 24484325
Oncogene. 2006 Oct 9;25(46):6188-96
pubmed: 17028598
Discoveries (Craiova). 2014 Mar 14;2(1):e10
pubmed: 32309542
Biomed Pharmacother. 2016 Dec;84:705-713
pubmed: 27701052
Mutat Res. 2005 Jan 6;569(1-2):29-63
pubmed: 15603751
Nature. 2014 Apr 3;508(7494):103-107
pubmed: 24670641
Mol Cell Ther. 2014 Mar 04;2:7
pubmed: 26056576
Expert Rev Mol Diagn. 2014 Jan;14(1):107-20
pubmed: 24308334
Methods. 2005 Apr;35(4):395-416
pubmed: 15804613
Gene. 2017 Jul 15;620:15-22
pubmed: 28363780

Auteurs

Azam Ahmadi (A)

Genetics, Arak University of Medical Sciences, Arak, IRN.

Reza Aghabozorgi (R)

Internal Medicine, Arak University of Medical Sciences, Arak, IRN.

Ali Arash Anoushirvani (AA)

Internal Medicine, Arak University of Medical Sciences, Arak, IRN.

Mohamadreza Bayatiani (M)

Radiotherapy and Medical Physics, Arak University of Medical Sciences, Arak, IRN.

Mohammad Arjomandzadegan (M)

Miscellaneous, Arak University of Medical Sciences, Arak, IRN.

Saeedeh Eslah (S)

Radiotherapy and Medical Physics, Arak University of Medical Sciences, Arak, IRN.

Yasaman Sobhani (Y)

Radiotherapy and Medical Physics, Arak University of Medical Sciences, Arak, IRN.

Classifications MeSH